Updates to ADA’s Handbook; Osteoporosis Patch Flops; Healthy Diet Prolongs Life

The American Diabetes Association (ADA) announced updates to its Standards of Medical Care in Diabetes to include new trial data, including EMPEROR-Preserved, PRESERVED-HF, FIDELIO-DKD, and FIGARO-DKD. Catch up on recent coverage from the ADA annual meeting here.

In response to a food additive petition, the FDA recently agreed to think again about the safety of BPA in products. The agency is expected to make a final decision by the end of October. (Environmental Defense Fund)

Radius Health said it’s pulling the plug on the company’s abaloparatide transdermal patch for osteoporosis after it missed the primary endpoint of non-inferiority to abaloparatide subcutaneous injection (Tymlos) in a phase III trial.

In an Australian study of more than 50,000 patients, obesity in women increased the need for a knee replacement due to osteoarthritis by 17.3 times. (ANZ Journal of Surgery)

No surprise here: eating a higher quality diet was tied with a lower risk of mortality, in a dose-dependent manner, according to a study of 1,770 Israeli participants ages 65 and older. (JAMA Network Open)

The FDA released a warning to consumers not to purchase products marketed with variations of the names “Artri” or “Ortiga,” sometimes promoted for treating osteoporosis and other conditions, due to potentially dangerous hidden active drug ingredients.

Gestational diabetes risk could be traced back to circulating extracellular vesicles from the placenta. (PLOS One)

Exactly which genetic factors may play into the role of immunological responses in type 1 diabetes? (eLife)